Business Categories Reports Podcasts Events Awards Webinars
Contact My Account About

Angela Caglia: NEXT50 2025

Published June 17, 2025
Published June 17, 2025
Angela Caglia

Launch Date: October 2018

Geography: Gardena, CA, US

Founders:

  • Angela Caglia, Co-Founder + Co-CEO
  • Robert Carliner, Co-Founder + Co-CEO

Executive Team:

  • Luca Del Carmine, SVP Marketing
  • Daniel Venezia, Director of Sales

2025 Full Year Projected Revenue: $8M - $10M, according to industry estimates

Primary Category: Skincare

Other Category: Tools/Devices

Funding: Self-Funded

Primary Distribution Channel: DTC

Other Distribution Channels:

  • Amazon
  • Department Store

Key Retail Partners:

  • Bluemercury
  • Nordstrom

2025 Projected Offline Distribution Points: 60

Angela Caglia Skincare is the first skincare line to commercialize human-derived stem cell technology, marking a breakthrough in the integration of regenerative medicine into topical skincare. Grounded in biotechnology, our formulations utilize ethically sourced human mesenchymal stem cell-derived growth factors and peptides—potent biosignaling molecules that promote dermal regeneration, stimulate collagen production, and restore skin barrier integrity.

This advanced approach addresses intrinsic aging and environmental damage at the cellular level, delivering visible improvements in skin texture, firmness, and overall resilience. Supporting the skin’s barrier function is central to our philosophy, as it is critical for maintaining hydration, regulating inflammation, and preventing accelerated aging. Each formula is thoughtfully developed to deliver transformative results while offering an elevated daily ritual that reflects the future of skincare: regenerative, results-driven, and uncompromising in quality.

Angela Caglia Skincare represents a new category of performance skincare—rooted in regenerative science, powered by biotechnology, and designed for those seeking more than surface-level results.

Insights: Angela Caglia, Co-Founder + Co-CEO

Why now and why you?

The skincare industry is at an inflection point. Consumers are moving beyond superficial trends and demanding clinically effective solutions rooted in science. At the same time, regenerative medicine—particularly human stem cell-derived growth factor technology—has advanced to a point where it can now be harnessed safely and effectively in topical formulations. The growing awareness of skin barrier health, accelerated by modern stressors and overuse of actives, has made next-generation, biologically intelligent skincare not only relevant, but essential. Angela Caglia Skincare is meeting this moment by bringing medical-grade innovation to consumers in an accessible, elevated form—and doing so as the first to commercialize human-derived stem cell technology in beauty.

My passion for regenerative science is both professional and deeply personal. I have spent years immersed in the study of skin biology, biomaterials, and ingredient chemistry. Beyond my hands-on skincare expertise, I’ve dedicated myself to understanding the science behind skin regeneration—particularly the role of growth factors and cellular signaling.

This passion took on new urgency as I witnessed my mother’s battle with Alzheimer’s disease and became deeply engaged with the emerging field of regenerative medicine. The promise of stem cell science—not just for neurological health, but for skin repair and barrier function—became more than academic; it became personal. That experience fueled my mission to apply this transformative science in a safe, effective way to skincare.

I founded Angela Caglia Skincare to bridge the gap between clinical innovation and everyday application—creating formulations that are biologically intelligent, barrier-supportive, and powered by human-derived stem cell technology. As the first to bring this level of regenerative science to beauty, I’m committed to leading with integrity, evidence-based efficacy, and a vision that goes far beyond the surface.

What fuels your competitive advantage?

What fuels our competitive advantage is our pioneering application of regenerative medicine in skincare—specifically, our early adoption and commercialization of human-derived stem cell growth factor technology. We are the first skincare brand to bring this breakthrough to market, giving us a powerful first-mover advantage in a space where consumers are increasingly demanding scientifically validated, biologically active solutions.

Our competitive edge is further strengthened by proprietary formulations developed in collaboration with leading biotech labs, ensuring not only clinical efficacy but also exclusivity in ingredient technology. These formulas are designed to repair and strengthen the skin barrier at a cellular level—a critical differentiator in an oversaturated market of superficial treatments.

Finally, this is a founder-led brand guided by the expertise of a celebrity master esthetician.  Decades of hands-on experience treating the world’s most discerning clientele and personal commitment to regenerative medicine drive innovation from the inside out—ensuring we don’t follow trends, we set them.

What are you most proud of accomplishing to date?

I’m most proud of being the first to bring human-derived stem cell technology into the skincare market—translating the promise of regenerative medicine into a product line that delivers real, measurable results. In an industry often dominated by trends and surface-level claims, launching a clinically backed, barrier-repairing line rooted in cutting-edge science has been both a bold move and a deeply meaningful one.

Equally important is the trust we’ve built with our retail and professional partners. To see Angela Caglia Skincare embraced not only by consumers, but also by top-tier estheticians and major retailers like Bluemercury—that recognize the efficacy and integrity behind the brand— is incredibly validating.

On a personal level, I’m proud that the brand reflects my values: authenticity, scientific rigor, and care. From formulation to education, we’ve maintained control over quality and messaging while scaling and have done so without compromising the original mission.

Creating something that merges true innovation with genuine human connection—and seeing it resonate at scale—is, without question, my proudest achievement to date.

"The future of beauty is personal, regenerative, and rooted in trust."
By Angela Caglia, Co-Founder + Co-CEO, Angela Caglia

What is the one thing you wish someone had told you?

I wish someone had told me that bringing true innovation to market means preparing to walk alone—at least at first. When you’re doing something that hasn’t been done before, whether it’s introducing human-derived stem cell technology in skincare or challenging conventional definitions of beauty, there won’t always be a roadmap—or immediate validation.

There were moments early on when I questioned whether the industry or consumers were ready for a science-backed, barrier-focused approach grounded in regenerative medicine. But staying true to that vision—even before it was “trendy”—has been the key to our success.

I’ve learned that conviction has to come before consensus. The beauty space moves fast, but real breakthroughs take time, courage, and patience. Had I known that earlier, I might have worried less and trusted my instincts more.

What would you tell your past self before starting this journey?

Don’t wait for permission. As a woman founder entering the biotech space, it’s easy to feel like you need credentials or validation from traditional gatekeepers. But lived experience, deep expertise, and a clear point of view are powerful currency.

I'd also tell myself to protect the joy. The science, the formulation, the creativity; it’s easy to get lost in operations and pressure. But that spark, that love for transforming skin and challenging what's possible, is what makes the whole journey worth it.

What does success look like in the next 3-5 years? 

Success in the next 3-5 years means turning Angela Caglia into more than just a skincare brand; it means leading a regenerative beauty movement that’s as much about science as it is about self-worth, ritual, and redefining what healthy skin looks and feels like.

We see our products on the top shelves of the world’s most beautiful bathrooms, in the hands of people who care as much about what goes into their formulas as they do about how they feel using them. Think: clinically backed, barrier-repairing skincare that looks gorgeous on your vanity and delivers biotech-level results.

We’ll expand into new doors globally, deepen our community through immersive events and partnerships, and grow our voice as a leader in the conversation around skin health, longevity, and confidence.

We want Angela Caglia to become a go-to for the skincare-obsessed and the science-curious alike—the brand people turn to when they’re ready to move into skincare that works, feels incredible, and fits beautifully into their lifestyle.

What's one industry trend that is overhyped, and what's being overlooked? 

Overhyped: Single-ingredient obsession. The industry loves to spotlight “hero” ingredients—whether it’s hyaluronic acid, retinol, or niacinamide—and market them like magic bullets. But skin health is complex and dynamic, and results don’t come from isolated actives. Overloading the skin with trendy ingredients, often without regard for barrier function or formulation synergy, is doing more harm than good.

Overlooked:The skin barrier and the power of regenerative biosignaling. While the conversation is finally starting to shift toward barrier repair, what’s still widely misunderstood is that true skin transformation doesn’t happen on the surface—it starts at the cellular level. That’s where human stem cell-derived growth factors come in. These biologically intelligent molecules don’t just treat symptoms; they help reprogram skin to act younger, heal better, and build resilience over time.

We’re only beginning to scratch the surface of what regenerative science can do for skin longevity. While the industry chases fast fixes, we’re focusing on long-term skin health and recovery—and that’s where the real revolution is happening.

How do you think the industry needs to evolve?

The beauty industry needs to evolve from being trend-driven to science-led—from quick fixes to long-term skin health. For too long, the focus has been on marketing hype, overly aggressive actives, and one-size-fits-all solutions that often compromise the skin barrier rather than support it.

We need to move toward a model that prioritizes biocompatibility, barrier integrity, and cellular regeneration—treating skin not as a canvas to correct, but as a living organ to nourish and support. That means embracing innovations from adjacent fields like biotechnology and regenerative medicine, and translating them into skincare that’s both effective and accessible.

Transparency also needs to go deeper than clean beauty buzzwords. Consumers are smart—they want to understand not just what’s in a product, but why it works, how it’s sourced, and what the long-term impact is on their skin and the planet.

Finally, the industry must stop underestimating the emotional connection people have with their skincare. We’re not just selling products; we’re shaping how people feel about themselves. The future of beauty is personal, regenerative, and rooted in trust.

If you could wave a magic wand, what one wish would you make for your business?

If I could wave a magic wand, I’d have every person ditch the 12-step routines, stop skin-cycling themselves into barrier damage, and finally experience what it feels like when your skincare is actually working with your skin—not just sitting on top of it.

I’d sprinkle some regenerative fairy dust (aka human stem cell-derived growth factors) across the industry so people stop obsessing over trends and start embracing real science—barrier-repairing, age-defying, results-you-can-see kind of science.

But really, my ultimate wish is for people to feel empowered and radiant in their skin—not because it’s perfect, but because they’re finally giving it what it actually needs.

×

2 Article(s) Remaining

Subscribe today for full access